E Fund Management Co. Ltd. purchased a new stake in Coherus BioSciences, Inc. (NASDAQ:CHRS – Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The fund purchased 45,010 shares of the biotechnology company’s stock, valued at approximately $168,000. Several other institutional investors also recently bought and sold shares of […]
Dorsey & Whitney Trust CO LLC bought a new stake in shares of Coherus BioSciences, Inc. (NASDAQ:CHRS – Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 10,410 shares of the biotechnology company’s stock, valued at approximately $39,000. A number of other large investors […]
Dorsey & Whitney Trust CO LLC acquired a new stake in shares of Coherus BioSciences, Inc. (NASDAQ:CHRS – Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 10,410 shares of the biotechnology company’s stock, valued at approximately $39,000. Several […]
Coherus BioSciences, Inc (NASDAQ:CHRS) Receives Average Rating of Moderate Buy from Brokerages theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Truist Financial Cuts Coherus BioSciences (NASDAQ:CHRS) Price Target to $8 00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.